Neauvia obtained the new CE marking under the European Union’s MDR (Medical Device Regulation) for its range of facial dermal fillers products guaranteeing clinical safety through a more stringent regulation process in comparison to its predecessor, the Medical Device Directive (MDD).

Gabriele Drigo, Neauvia’s founder and CEO, commented: “The MDR was created with the goal of enhancing overall transparency, creating better access to information on medical products for both the public and healthcare professionals. Due to the dedication and hard work of the team, we are now able to confirm that our facial dermal fillers have successfully passed this rigorous process which should give the medical community and our customers the upmost confidence when using facial dermal filler products recognised by MDR.”